- What is percutaneous nucleoplasty?
- How does the coblation mechanism work?
- Who is actually a candidate?
- What does the evidence show?
- Risks and alternatives
01 What is percutaneous nucleoplasty?
Percutaneous nucleoplasty is a minimally invasive procedure — performed through a needle, without an open incision — that uses coblation technology, low-temperature bipolar radiofrequency energy, to remove a small amount of tissue from the nucleus pulposus, the gel-like center of the intervertebral disc.
It descends from a lineage of percutaneous spine procedures: Hijikata's aspiration nucleotomy in the 1970s and Onik's aspiration-probe discectomy in the 1980s (Hijikata, 1975; Onik et al., 1985), and the posterolateral percutaneous approaches described by Kambin around the same time (Kambin & Brager, 1987; Kambin & Schaffer, 1989). It also shares its underlying goal with enzymatic chemonucleolysis, in use since the 1960s (Smith, 1964; Brown, 1996): reducing disc volume to relieve nerve root pressure.
The goal is not to "remove the herniation" in the sense of extracting the herniated fragment, but to reduce intradiscal pressure. In contained herniations — where the outer annulus fibrosus is still intact — lowering that pressure tends to allow the protruded material to retract partially, reducing compression on the nerve root.
Nucleoplasty does not remove disc material by force — it lowers internal disc pressure so a contained herniation can retract on its own.
Want to know if your MRI shows a contained herniation?
Request an evaluation"Coblation" is short for controlled ablation. Unlike traditional electrocautery, it does not work by heat. The electrode tip sits in a conductive medium (typically saline), and radiofrequency energy excites the ions in that fluid into a thin layer of ionized plasma around the tip. That plasma carries enough energy to break the molecular bonds of soft tissue directly — dissolving it, in effect — without needing to reach high temperatures. It is the same underlying technology used in ENT (tonsillectomy) and orthopedic arthroscopy; its use in percutaneous disc nucleoplasty is an adaptation of that same principle.
| Coblation | Traditional electrocautery | |
|---|---|---|
| Temperature | ~40–70°C | >100°C |
| Mechanism | Molecular breakdown by plasma | Burning by heat |
| Damage to nearby tissue | Minimal | Greater thermal spread |
Coblation does not burn tissue the way traditional electrocautery does. It generates a low-temperature plasma field — typically 40–70°C — around the electrode tip, breaking molecular bonds in soft tissue with minimal heat spread to nearby structures, as measured directly in cadaveric spine (Nau & Diederich, 2004).
Cadaveric studies have measured a quantifiable reduction in intradiscal pressure from this process (Chen et al., 2003a). Histologic studies in animal models confirm controlled ablation of the nucleus pulposus without extensive thermal damage to the vertebral endplate or the annulus fibrosus (Chen et al., 2003b; Lee et al., 2003). Additional animal models show reduced local inflammatory markers — phospholipase A2 and IL-1β — within the treated disc (Xu et al., 2016; Ren et al., 2015), and biomechanical studies in a porcine model document the effect of heating on disc properties (Wang et al., 2005; O'Neill et al., 2004).
Nucleoplasty makes clinical sense only for a specific patient profile, defined per standardized disc classification and nomenclature criteria (Fardon & Milette, 2001; Fardon et al., 2014).
- A contained disc herniation (the outer annulus fibrosus is not torn), confirmed by MRI.
- Radicular pain (sciatica), with or without a discogenic low-back-pain component, attributable to that herniation.
- Failure of at least 6–8 weeks of conservative treatment.
- No progressive neurological deficit, cauda equina syndrome, or significant bony canal stenosis.
- Extruded or sequestered herniation.
- Markedly reduced disc height.
- Canal stenosis from bony causes (Fardon & Milette, 2001; Fardon et al., 2014; Postacchini, 1999).
- Case series with 1–2 year follow-up report significant improvement in well-selected patients (Singh et al., 2002; Mirzai et al., 2007; Yakovlev et al., 2007; Kasch et al., 2012; Shabat et al., 2012; Azzazi et al., 2011).
- Additional series across technical variants (Dekompressor, single- vs. dual-portal access, ultrahigh-field MRI volumetry follow-up) show results in the same direction, though mostly observational in design (Karaman et al., 2011; Zhu et al., 2011; Sinan et al., 2011; Lemcke et al., 2010; Bokov et al., 2010).
- Systematic reviews and meta-analyses conclude that the available methodological quality is limited — few randomized trials, small sample sizes, no true placebo arm in most of them (Gerges et al., 2010; Eichen et al., 2014).
- Manchikanti et al.’s systematic review rated the evidence as limited for short- and long-term pain relief, not as solid Level I evidence (Manchikanti et al., 2009).
- The largest available randomized controlled trial compared nucleoplasty against fluoroscopy-guided transforaminal epidural steroid injections for symptomatic contained lumbar disc herniation (Gerszten et al., 2010).
- The Cochrane review on surgical interventions for lumbar disc prolapse, which synthesizes open-surgery evidence as the standard comparator, does not include nucleoplasty among techniques with consolidated surgical evidence (Gibson & Waddell, 2009).
- There are reports of accelerated disc degeneration in cases where the procedure was not clinically successful, underscoring that this is not a consequence-free procedure when applied to the wrong patient (Cuellar et al., 2010).
- Outpatient, under conscious sedation and local anesthesia, with real-time fluoroscopic guidance.
- A needle is advanced to the center of the disc via a posterolateral approach, following the technique originally described for percutaneous discectomy (Kambin & Brager, 1987; Kambin & Schaffer, 1989), avoiding nerve structures.
- The coblation electrode is passed through the needle and creates several channels inside the nucleus pulposus to reduce volume and pressure.
- Instruments are withdrawn; no suturing is needed beyond the puncture site.
- Brief observation, and the patient typically goes home the same day.
Because it is percutaneous, there is no traditional surgical wound to heal. Most patients resume light activity within a few days, avoiding significant lumbar strain during the first weeks as directed by their physician.
Improvement in radicular pain is not always immediate: in several studies the clinical effect consolidates between weeks 4 and 6, and mid-term results (6–12 months) are what actually determine whether the procedure was successful (Mirzai et al., 2007; Shabat et al., 2012).
- Epidural fibrosis documented after the procedure in some patients (Smuck et al., 2007).
- Side effects and complications described specifically for coblation technology, including transient pain at the puncture site.
- Persistent pain or lack of improvement if the patient did not fit the ideal candidate profile.
- Accelerated disc degeneration in cases of procedural failure (Cuellar et al., 2010).
Open disc surgery has its own well-documented intra- and postoperative complication rates (Stolke et al., 1989).
| Technique | Mechanism | Available evidence |
|---|---|---|
| Coblation (nucleoplasty) | Low-temperature ionic plasma (~40–70°C) | 1–2 year case series; systematic reviews rate it as limited-quality evidence |
| Laser (PLDD) | Thermal vaporization via optical fiber | One of the oldest percutaneous methods (since the 1980s); its own systematic review also rates the evidence as limited |
| Chemonucleolysis | Enzyme or ethanol gel dissolves nucleus material | Historic technique since the 1960s; largely abandoned due to allergic reactions |
| Mechanical (Dekompressor) | Physical extraction via helical auger | Compared directly against coblation in one study, with similar results |
No randomized trial has directly compared coblation against laser (Ohnmeiss et al., 1994; Nerubay et al., 1997) in the same patient population with long-term follow-up. The separate systematic reviews of each technique reach the same conclusion (Singh et al., 2009): case series report improvement, but methodological quality is limited in both, as also shown in a direct comparison against the Dekompressor mechanical device (Lemcke et al., 2010). There is no solid evidence that one is superior to the other.
Some interventional radiology sources use the term “cryoablation” to describe this same plasma-based mechanism — not actual freezing (Kelekis et al., 2010). There is no clinical evidence of a true cold-based (freezing) technique applied to reduce nucleus pulposus volume; cold energy is used elsewhere in spine care (facet joint cryoneurolysis), but that is a different procedure for a different indication.
Depending on the type of herniation and how the patient has progressed, other paths include extended conservative treatment, image-guided epidural or transforaminal injections as an intermediate step for radicular pain, and open microdiscectomy — the traditional surgical standard for extruded herniations or neurological deficit, with its own evidence base synthesized in Cochrane reviews.
The only study specifically designed to measure this — a 10-year retrospective review — found a re-surgery rate of 18.7% at the treated level, despite 63.5% patient satisfaction shortly after the procedure. The author explicitly concluded that indications for nucleoplasty should be critically reconsidered.
A separate cohort study found an overall reoperation rate of 11.4%, but with a sharp difference by extent of treatment: 6.7% when only one disc level was treated, versus 23.3% when two levels were treated in the same session (Yin et al., 2021). Other, more loosely selected cohorts cited in that same literature report reoperation as high as 51.9% — a spread wide enough on its own to show how much patient selection changes the outcome.
Yes, in patients where the procedure works — and the numbers are documented. In one prospective study of 52 patients (Mirzai et al., 2007), the mean VAS pain score dropped from 7.5 before the procedure to 3.5 at two weeks and 2.1 at one year, with patient satisfaction of 81%, 85%, and 88% at those same intervals.
Functional improvement follows a similar but less linear pattern. In a study with two-year follow-up (Zhu et al., 2011), the Oswestry Disability Index (ODI) improved from 68.2% before the procedure to 28.6% at one week — but partially regressed to 35.8% at one year and 39.4% at two years. Another study (Karaman et al., 2011) found the same pattern: ODI dropped sharply in the first weeks, then crept back up, reaching 36.98% by month 24. This partial regression over time is exactly why systematic reviews describe the evidence as limited rather than definitive — the short-term improvement is real and measurable, but it does not always hold at the same magnitude years later.
A final reflection
The results reported across the nucleoplasty literature are notably variable — from centers reporting 88% patient satisfaction (Mirzai et al., 2007) to cohorts where more than half of patients eventually needed further surgery (Yin et al., 2021). That variability is not random: it tracks closely with how strictly patient selection was applied. Series that stuck to contained herniations, appropriate symptom duration, and clear imaging criteria report the results summarized above; series with looser criteria are the ones behind the reoperation rates above 50% (Klessinger, 2018).
That is the honest summary of this technique: it can offer real, measurable relief in the right patient, but a meaningful share of patients — in some published series, over half (Manchikanti et al., 2009) — end up needing surgery within a few years regardless. Anyone considering nucleoplasty should treat the candidate criteria in this article, not the best-case percentages, as the part that determines the outcome.